CD274 and non-small cell lung carcinoma: However, the predictive power of microenvironment phenotyping based on TIL and PD-L1 expression, has demonstrated weaker predictive potential outside melanoma and non-small cell lung cancer, where, unlike HCC, PD-L1 has emerged as a companion diagnostic tool for the identification of patients who may benefit from immunotherapy.44